Product Information

LOSARTAN POTASSIUM 50 MG TAB is a generic product labeled by Unichem Pharmaceuticals (USA) Inc., priced at $0.0324 per EA under NDC 29300014519. Its NADAC has been published 212 times since Jun 1, 2022.

FDA first approved this application on Oct 14, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Losartan Potassium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

LOSARTAN POTASSIUM 50 MG TAB

Losartan Potassium
$0.0324per EA
High Outlier

Strength

50 mg/1

NDC

29300014519

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LOSARTAN POTASSIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA203030

FDA Approved

10/14/2015

TE Code

AB

On Market Since

10/14/2015

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker

Price Statistics

The NADAC for LOSARTAN POTASSIUM 50 MG TAB has been published 212 times since Jun 1, 2022, and over the history we have for it it has declined 51.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0324 per EA
All-time high$0.0694 (Aug 10, 2022)
All-time low$0.0304 (Nov 19, 2025)
52-week high$0.0343
52-week low$0.0304
Median price$0.0387
Average price$0.0418
Largest weekly change-23.1% (Nov 20, 2024)
Weeks tracked212
Tracking sinceJun 1, 2022

Price History

1W

-2.5%

1M

-2.5%

3M

-5.5%

6M

+2.0%

1Y

-5.5%

3Y

-28.4%

5Y

N/A

All

-51.9%

Generic Alternatives

The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LOSARTAN POTASSIUM 50 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for LOSARTAN POTASSIUM 50 MG TAB, manufactured by Unichem Pharmaceuticals (USA) Inc., is $0.0324 per EA (NDC 29300014519), effective Aug 19, 2026.

How has the price of LOSARTAN POTASSIUM 50 MG TAB changed over time?

Over the history we have for it, the NADAC for LOSARTAN POTASSIUM 50 MG TAB has declined 51.9%. It has been tracked across 212 weekly CMS publications since Jun 1, 2022.

What are the highest and lowest recorded NADAC prices for LOSARTAN POTASSIUM 50 MG TAB?

Since Jun 1, 2022, the NADAC for LOSARTAN POTASSIUM 50 MG TAB has ranged from a low of $0.0304 (Nov 19, 2025) to a high of $0.0694 (Aug 10, 2022), with a median of $0.0387 per EA.

Are there cheaper alternatives to LOSARTAN POTASSIUM 50 MG TAB?

Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LOSARTAN POTASSIUM 50 MG TAB, is $0.0315 per EA — about 3% below LOSARTAN POTASSIUM 50 MG TAB.

Who manufactures LOSARTAN POTASSIUM 50 MG TAB?

LOSARTAN POTASSIUM 50 MG TAB (NDC 29300014519) is labeled by Unichem Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.